Journal of Bioenergetics and Biomembranes

, Volume 42, Issue 1, pp 55–67 | Cite as

Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia

  • Katarína Smolková
  • Nadège Bellance
  • Francesca Scandurra
  • Elisabeth Génot
  • Erich Gnaiger
  • Lydie Plecitá-Hlavatá
  • Petr Ježek
  • Rodrigue RossignolEmail author


Breast cancer cells can survive and proliferate under harsh conditions of nutrient deprivation, including limited oxygen and glucose availability. We hypothesized that such environments trigger metabolic adaptations of mitochondria, which promote tumor progression. Here, we mimicked aglycemia and hypoxia in vitro and compared the mitochondrial and cellular bioenergetic adaptations of human breast cancer (HTB-126) and non-cancer (HTB-125) cells that originate from breast tissue. Using high-resolution respirometry and western blot analyses, we demonstrated that 4 days of glucose deprivation elevated oxidative phosphorylation five-fold, increased the spread of the mitochondrial network without changing its shape, and decreased the apparent affinity of oxygen in cancer cells (increase in C 50 ), whereas it remained unchanged in control cells. The substrate control ratios also remained constant following adaptation. We also observed the Crabtree effect, specifically in HTB-126 cells. Likewise, sustained hypoxia (1% oxygen during 6 days) improved cell respiration in non-cancer cells grown in glucose or glucose-deprived medium (+ 32% and +38%, respectively). Conversely, under these conditions of limited oxygen or a combination of oxygen and glucose deprivation for 6 days, routine respiration was strongly reduced in cancer cells (−36% in glucose medium, −24% in glucose-deprived medium). The data demonstrate that cancer cells behave differently than normal cells when adapting their bioenergetics to microenvironmental conditions. The differences in hypoxia and aglycemia tolerance between breast cancer cells and non-cancer cells may be important when optimizing strategies for the treatment of breast cancer.


Mitochondria Oxidative phosphorylation Breast cancer Tumor bioenergetics Hypoxia Respirometry 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Acebo P, Giner D, Calvo P, Blanco-Rivero A, Ortega AD, Fernandez PL, Roncador G, Fernandez-Malave E, Chamorro M, Cuezva JM (2009) Transl Oncol 2:138–145Google Scholar
  2. Arismendi-Morillo G (2009) Int J Biochem Cell Biol 41:2062–2068CrossRefGoogle Scholar
  3. Arismendi-Morillo GJ, Castellano-Ramirez AV (2008) J Electron Microsc (Tokyo) 57:33–39CrossRefGoogle Scholar
  4. Baffert F, Usson Y, Tranqui L (2001) Eur J Cell Biol 80:78–86CrossRefGoogle Scholar
  5. Bellance N, Benard G, Furt F, Begueret H, Smolkova K, Passerieux E, Delage J, Baste J, Moreau P, Rossignol R (2009) Int J Biochem Cell BiolGoogle Scholar
  6. Bellance N, Lestienne P, Rossignol R (2009b) Front Biosci 14:4015–4034Google Scholar
  7. Benard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T, Rossignol R (2007) J Cell Sci 120:838–848CrossRefGoogle Scholar
  8. Benard G, Faustin B, Passerieux E, Galinier A, Rocher C, Bellance N, Delage JP, Casteilla L, Letellier T, Rossignol R (2006) Am J Physiol Cell PhysiolGoogle Scholar
  9. Borenfreund E, Puerner JA (1985) Toxicol Lett 24:119–124CrossRefGoogle Scholar
  10. Bratslavsky G, Sudarshan S, Neckers L, Linehan WM (2007) Clin Cancer Res 13:4667–4671CrossRefGoogle Scholar
  11. Chatterjee A, Mambo E, Sidransky D (2006) Oncogene 25:4663–4674CrossRefGoogle Scholar
  12. Crabtree HG (1928) Biochem J 22:1289–1298Google Scholar
  13. Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, Beer DG (2004) Carcinogenesis 25:1157–1163CrossRefGoogle Scholar
  14. Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H, Zapata JM, Marusawa H, Chamorro M, Reed JC (2002) Cancer Res 62:6674–6681Google Scholar
  15. Cuezva JM, Ostronoff LK, Ricart J, Lopez de Heredia M, Di Liegro CM, Izquierdo JM (1997) J Bioenerg Biomembr 29:365–377CrossRefGoogle Scholar
  16. Denko NC (2008) Nat Rev Cancer 8:705–713CrossRefGoogle Scholar
  17. Diaz-Ruiz R, Averet N, Araiza D, Pinson B, Uribe-Carvajal S, Devin A, Rigoulet M (2008) J Biol Chem 283:26948–26955CrossRefGoogle Scholar
  18. Donnely M, Scheffler I (1976) J cell Physiol 89:39–52CrossRefGoogle Scholar
  19. Dufour SP, Ponsot E, Zoll J, Doutreleau S, Lonsdorfer-Wolf E, Geny B, Lampert E, Fluck M, Hoppeler H, Billat V, Mettauer B, Richard R, Lonsdorfer J (2006) J Appl Physiol 100:1238–1248CrossRefGoogle Scholar
  20. Essop MF (2007) J Physiol 584:715–726CrossRefGoogle Scholar
  21. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV (2009) Nature 458:762–765CrossRefGoogle Scholar
  22. Gatenby RA, Gillies RJ (2004) Nat Rev Cancer 4:891–899CrossRefGoogle Scholar
  23. Gatenby RA, Gillies RJ (2008) Nat Rev Cancer 8:56–61CrossRefGoogle Scholar
  24. Gnaiger E (2001) Respir Physiol 128:277–297CrossRefGoogle Scholar
  25. Gnaiger E (2008) Polarographic oxygen sensors, the oxygraph and high-resolution respirometry to assess mitochondrial function. In Mitochondrial dysfunction in drug-induced toxicity. D.J.a.W. Y, ed. (Wiley), pp. 327–352Google Scholar
  26. Gnaiger E (2009) Int J Biochem Cell Biol 41:1837–1845CrossRefGoogle Scholar
  27. Gnaiger E, Kemp RB (1990) Biochim Biophys Acta 1016:328–332CrossRefGoogle Scholar
  28. Gnaiger E, Lassnig B, Kuznetsov AV, Margreiter R (1998) Biochim Biophys Acta 1365:249–254CrossRefGoogle Scholar
  29. Gnaiger E, Steinlechner-Maran R, Mendez G, Eberl T, Margreiter R (1995) J Bioenerg Biomembr 27:583–596CrossRefGoogle Scholar
  30. Gstraunthaler G, Seppi T, Pfaller W (1999) Cell Physiol Biochem 9:150–172CrossRefGoogle Scholar
  31. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB (2005) Cancer Cell 8:311–321CrossRefGoogle Scholar
  32. Hutter E, Renner K, Pfister G, Stockl P, Jansen-Durr P, Gnaiger E (2004) Biochem J 380:919–928CrossRefGoogle Scholar
  33. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J (2008) Science 320:661–664CrossRefGoogle Scholar
  34. Ježek P, Plecitá-Hlavatá L, Smolkova K, Rossignol R (2009) Int J Biochem Cell BiolGoogle Scholar
  35. John AP (2001) Med Hypotheses 57:429–431CrossRefGoogle Scholar
  36. Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) Cell Metab 3:177–185CrossRefGoogle Scholar
  37. King A, Selak MA, Gottlieb E (2006) Oncogene 25:4675–4682CrossRefGoogle Scholar
  38. Kroemer G, Pouyssegur J (2008) Cancer Cell 13:472–482CrossRefGoogle Scholar
  39. Liu H, Savaraj N, Priebe W, Lampidis TJ (2002) Biochem Pharmacol 64:1745–1751CrossRefGoogle Scholar
  40. Mathupala SP, Rempel A, Pedersen PL (1997) J Bioenerg Biomembr 29:339–343CrossRefGoogle Scholar
  41. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E (2007) Febs J 274:1393–1418CrossRefGoogle Scholar
  42. Nouette-Gaulain K, Bellance N, Prevost B, Passerieux E, Pertuiset C, Galbes O, Smolkova K, Masson F, Miraux S, Delage JP, Letellier T, Rossignol R, Capdevila X, Sztark F (2009) Anesthesiology 110:648–659CrossRefGoogle Scholar
  43. Pecina P, Gnaiger E, Zeman J, Pronicka E, Houstek J (2004) Am J Physiol Cell Physiol 287:C1384–1388CrossRefGoogle Scholar
  44. Pedersen P (1978) Tumor mitochondria and the bioenergetic of cancer cells. In: Karger S (ed) Progress in experimental tumor research. Basel, New York, pp 190–274Google Scholar
  45. Pedersen PL (2007) J Bioenerg Biomembr 39:211–222CrossRefGoogle Scholar
  46. Plecitá-Hlavatá L, Lessard M, Šantorová J, Bewersdorf J, Ježek P (2008) Biochim Biophys Acta 1777:834–846CrossRefGoogle Scholar
  47. Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ, Hargreaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath JA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, Tomlinson IP (2005) Hum Mol Genet 14:2231–2239CrossRefGoogle Scholar
  48. Reitzer L, Wice B, Kennel D (1979) JBC 254:2669–2676Google Scholar
  49. Rodriguez-Enriquez S, Juarez O, Rodriguez-Zavala JS, Moreno-Sanchez R (2001) Eur J Biochem 268:2512–2519CrossRefGoogle Scholar
  50. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, Capaldi RA (2004) Cancer Res 64:985–993CrossRefGoogle Scholar
  51. Simonnet H, Alazard N, Pfeiffer K, Gallou C, Beroud C, Demont J, Bouvier R, Schagger H, Godinot C (2002) Carcinogenesis 23:759–768CrossRefGoogle Scholar
  52. Simonnet H, Demont J, Pfeiffer K, Guenaneche L, Bouvier R, Brandt U, Schagger H, Godinot C (2003) Carcinogenesis 24:1461–1466CrossRefGoogle Scholar
  53. Steinlechner-Maran R, Eberl T, Kunc M, Margreiter R, Gnaiger E (1996) Am J Physiol 271:C2053–2061Google Scholar
  54. Vaupel P (2008) Oncologist 13(3):21–26CrossRefGoogle Scholar
  55. Vaupel P, Hockel M (2000) Int J Oncol 17:869–879Google Scholar
  56. Vaupel P, Hockel M, Mayer A (2007) Antioxid Redox Signal 9:1221–1235CrossRefGoogle Scholar
  57. Vaupel P, Mayer A (2005) Effects of anemia and hypoxia on tumor biology. In Anemia in Cancer. European scholl of oncology scientific updates. C. Bokemeyer, and H. Ludwig, eds., pp. 47–54.Google Scholar
  58. Vaupel P, Mayer A, Briest S, Hockel M (2003) Cancer Res 63:7634–7637Google Scholar
  59. Ventura-Clapier R, Garnier A, Veksler V (2008) Cardiovasc Res 79:208–217CrossRefGoogle Scholar
  60. Warburg (1930) Metabolisn of tumors. Arnold Constable, LondonGoogle Scholar
  61. Willems PH, Smeitink JA, Koopman WJ (2009) Int J Biochem Cell Biol 41:1773–1782CrossRefGoogle Scholar
  62. Zu XL, Guppy M (2004) Biochem Biophys Res Commun 313:459–465CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Katarína Smolková
    • 1
    • 2
    • 6
  • Nadège Bellance
    • 1
    • 2
  • Francesca Scandurra
    • 3
  • Elisabeth Génot
    • 4
  • Erich Gnaiger
    • 5
  • Lydie Plecitá-Hlavatá
    • 6
  • Petr Ježek
    • 6
  • Rodrigue Rossignol
    • 1
    • 2
    Email author
  1. 1.INSERM U688BordeauxFrance
  2. 2.Université Victor Segalen Bordeaux 2BordeauxFrance
  3. 3.OROBOROS INSTRUMENTSInnsbruckAustria
  4. 4.INSERM U889, IECBPessacFrance
  5. 5.Department of General and Transplant Surgery, D. Swarovski Research LaboratoryMedical University of InnsbruckInnsbruckAustria
  6. 6.Institute of Physiology, Dept. 75Academy of Sciences of the Czech RepublicPragueCzech Republic

Personalised recommendations